Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
20.3 USD | -3.31% | -4.43% | -15.42% |
20/05 | Exelixis Settles Cabometyx Patent Litigation with Cipla | MT |
14/05 | Transcript : Exelixis, Inc. Presents at 2024 RBC Capital Markets Global Healthcare Conference, May-14-2024 02:35 PM |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.49% | 6.12B | |
+10.60% | 115B | |
+12.14% | 106B | |
-4.49% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-13.77% | 17.56B | |
-40.50% | 17.32B | |
+5.93% | 14.03B | |
+30.64% | 12.13B |
- Stock Market
- Equities
- EXEL Stock
- News Exelixis, Inc.
- Insider Sell: Exelixis